Human Various Tissue MicroArray (Cancer)

Images

 
Hematoxylin & Eosin Stain: Human Various Tissue MicroArray (Cancer) [NBP2-30329] - Partoid gland actnic cell carcinoma

Product Details

Summary
Reactivity HuSpecies Glossary
Applications IHC-P

Order Details

Human Various Tissue MicroArray (Cancer) Summary

Description
Microarray Panel:
Various cancers, high density (1)
No. of samples 146
No. of patients 146
Core diameter 1.0 mm
Format:Formalin Fixed
Section thickness 4 micrometer
Core#
No.
Age Sex Organ Diagnosis pTNM Stage Tissue
type
1 44 M Oral cavity, tongue squamous cell carcinoma, well differentiated T2N0M0 II 6
2 55 M Oral cavity, tongue squamous cell carcinoma, well differentiated T2N0M0 II 6
3 55 M Oral cavity, lower lip squamous cell carcinoma, well differentiated T3N0M0 III 6
4 68 M Oral cavity, mandible squamous cell carcinoma, well differentiated T2N2bM0 IVA 6
5 38 M Oral cavity, maxilla squamous cell carcinoma, moderately differentiated T3N1M0 III 6
6 45 M Oral cavity, maxilla squamous cell carcinoma, moderately differentiated T2N0M0 II 6
7 58 M Oral cavity, tonsil squamous cell carcinoma, well differentiated T3N0M0 III 6
8 23 M Nasopharynx angiofibroma T1N0M0 I 4
9 26 M Nasopharynx olfactory neuroblastoma T1N0M0 I 6
10 19 F Nasopharynx olfactory neuroblastoma T1N0M0 I 6
11 35 M Nasopharynx olfactory neuroblastoma, recurrent, extension to orbit T1N0M0 I 6
12 32 F Nasopharynx olfactory neuroblastoma T1N0M0 I 6
13 52 F Nasopharynx undifferentiated carcinoma T1N0M0 I 6
14 62 M Salivary gland, parotid acinic cell carcinoma T3N0M0 III 6
15 53 M Salivary gland, parotid acinic cell carcinoma T3N1M0 III 6
16 56 F Salivary gland, parotid acinic cell carcinoma T2N0M0 II 6
17 51 F Salivary gland, parotid adenoid cystic carcinoma T4aN0M0 IVA 6
18 72 F Salivary gland, submandibular adenoid cystic carcinoma T4aN0M0 IVA 6
19 53 F Salivary gland adenoid cystic carcinoma, metastasis to breast M1 IVC 6
20 21 F Salivary gland, parotid mucoepidermoid carcinoma, low grade T3N2bM0 IVA 6
21 31 F Salivary gland, parotid mucoepidermoid carcinoma, intermediate grade T3N0M0 III 6
22 61 M Salivary gland, parotid epithelial myoepithelial carcinoma T3N0M0 III 6
23 42 M Salivary gland, parotid myoepithelioma, malignant, recurrent T2N0M0 II 6
24 32 F Salivary gland, parotid carcinoma ex pleomorphic adenoma T2N0M0 II 6
25 35 F Salivary gland, submandibular carcinoma ex pleomorphic adenoma T4aN0M0 IVA 6
26 64 M Salivary gland, parotid carcinoma ex pleomorphic adenoma T1N0M0 I 6
27 80 F Salivary gland, parotid carcinoma ex pleomorphic adenoma T3N0M0 III 6
28 57 M Salivary gland, parotid squamous cell carcinoma T3N2bM0 IVA 6
29 52 M Esophagus squamous cell carcinoma, moderately differentiated T3N1M0 III 6
30 60 M Esophagus squamous cell carcinoma, moderately differentiated T3N0M0 IIA 6
31 62 M Esophagus squamous cell carcinoma, well differentiated T3N0M0 IIA 6
32 54 F Stomach adenocarcinoma, well differentiated T3N3M0 IV 6
33 52 M Stomach adenocarcinoma, well differentiated T3N0M0 II 6
34 65 M Stomach adenocarcinoma, moderately differentiated T3N0M0 II 6
35 50 M Stomach adenocarcinoma, moderately differentiated T3N3M0 IV 6
36 61 M Stomach adenocarcinoma, moderately differentiated T3N1M0 IIIA 6
37 60 M Stomach adenocarcinoma, moderately differentiated T2aN0M0 I B 6
38 62 M Stomach adenocarcinoma, moderately differentiated T3N1M0 IIIA 6
39 50 M Stomach adenocarcinoma, poorly differentiated T3N1M0 IIIA 6
40 53 M Stomach adenocarcinoma, poorly differentiated T3N3M0 IV 6
41 62 M Stomach adenocarcinoma, poorly differentiated T2aN0M0 I B 6
42 55 F Stomach adenocarcinoma, poorly differentiated T3N0M0 II 6
43 32 F Stomach adenocarcinoma, poorly differentiated T3N1M0 IIIA 6
44 56 F Stomach adenocarcinoma, poorly differentiated T3N2M0 IIIB 6
45 . . Carbon . . . .
46 52 M Stomach adenocarcinoma, poorly differentiated T3N3M0 IV 6
47 29 M Stomach adenocarcinoma, poorly differentiated T3N3M0 IV 6
48 68 F Stomach adenocarcinoma, poorly differentiated T2bN1M1 IV 6
49 55 M Stomach adenocarcinoma, poorly differentiated T3N1M0 IIIA 6
50 52 M Stomach adenocarcinoma, poorly differentiated T3N2M0 IIIB 6
51 58 M Stomach adenocarcinoma, mucinous T3N1M0 IIIA 6
52 71 M Stomach adenocarcinoma, mucinous T3N3M0 IV 6
53 43 F Stomach adenocarcinoma, metastasis to ovary M1 IV 6
54 53 F Stomach adenocarcinoma, metastasis to ovary M1 IV 6
55 47 F Stomach adenocarcinoma, metastasis to ovary M1 IV 6
56 28 F Stomach adenocarcinoma, metastasis to ovary M1 IV 6
57 61 F Stomach adenocarcinoma, metastasis to ovary M1 IV 6
58 36 F Stomach adenocarcinoma, metastasis to ovary, signet ring cell M1 IV 6
59 39 F Stomach adenocarcinoma, metastasis to ovary, mucinous M1 IV 6
60 37 F Stomach adenocarcinoma, metastasis to ovary, signet ring cell M1 IV 6
61 50 M Stomach adenocarcinoma, metastasis to lymph node T3N3M0 IV 6
62 41 F Stomach adenocarcinoma, metastasis to lymph nodes, papillary T1N3M0 IV 6
63 55 F Stomach gastrointestinal stromal tumor T1aN0M0 I 3
64 39 M Small intestine, jejunum gastrointestinal stromal tumor, malignant T2bN0M0 0 6
65 54 M Small intestine, jejunum gastrointestinal stromal tumor, malignant T2bN0M0 I 6
66 55 M Small intestine, jejunum gastrointestinal stromal tumor, malignant T2bN1M0 IV 6
67 42 M Small intestine gastrointestinal stromal tumor, malignant T2bN0M0 0 6
68 61 M Small intestine, duodenum adenocarcinoma, metastasis to lymph node T4N1M1 IV 6
69 44 F Colon, sigmoid villotubular adenomas T1N0M0 I 4
70 52 M Colon, ascending adenocarcinoma, well differentiated T3N0M0 IIA 6
71 71 F Colon, sigmoid adenocarcinoma, well differentiated T3N0M0 IIA 6
72 82 F Colon, cecum adenocarcinoma, well differentiated T3N2M0 IIIC 6
73 50 F Colon, sigmoid adenocarcinoma, well differentiated T3N0M0 IIA 6
74 48 F Colon, ascending adenocarcinoma, well differentiated T3N1M0 IIIB 6
75 54 F Colon adenocarcinoma, well differentiated T3N1M1 IV 6
76 73 F Colon adenocarcinoma, well differentiated, recurrent . . 6
77 62 F Colon, descending adenocarcinoma, moderately differentiated T3N0M0 IIA 6
78 46 M Colon, sigmoid adenocarcinoma, moderately differentiated T3N0M0 IIA 6
79 73 F Colon, cecum adenocarcinoma, moderately differentiated T3N0M0 IIA 6
80 72 F Colon, cecum adenocarcinoma, moderately differentiated T3N1M0 IIIB 6
81 37 F Colon, ascending adenocarcinoma, poorly differentiated T3N1M0 IIIB 6
82 44 M Colon, ascending adenocarcinoma, mucinous T3N2M0 IIIC 6
83 69 F Colon, transverse adenocarcinoma, mucinous T3N0M0 IIA 6
84 31 M Colon, cecum undifferentiated carcinoma T3N0M0 IIA 6
85 42 F Colon adenocarcinoma, metastasis to uterus, mucinous M1 IV 6
86 59 M Colon, ascending adenocarcinoma, metastasis to liver, moderately differentiated M1 IV 6
87 51 F Rectum adenocarcinoma, well differentiated T3N2M0 IIIC 6
88 75 F Rectum adenocarcinoma, well differentiated T2N0M0 I 6
89 43 M Rectum adenocarcinoma, well differentiated T3N1M0 IIIB 6
90 60 M Rectum adenocarcinoma, well differentiated T3N1M0 IIIB 6
91 55 F Rectum adenocarcinoma, well differentiated T3N1M0 IIIB 6
92 63 F Rectum adenocarcinoma, moderately differentiated T3N2M0 IIIC 6
93 55 M Rectum adenocarcinoma, moderately differentiated T3N0M0 IIA 6
94 63 F Rectum adenocarcinoma, moderately differentiated T3N0M0 IIA 6
95 . . Carbon . . . .
96 70 M Rectum adenocarcinoma, moderately differentiated T3N0M0 IIA 6
97 61 F Anus squamous cell carcinoma T4N0M0 IIIA 6
98 63 M Liver cholangiocarcinoma, poorly differentiated T1N0M0 I 6
99 41 M Liver cholangiocarcinoma, moderately differentiated T4N0M0 IIIB 6
100 56 M Liver cholangiocarcinoma, moderately differentiated T4N0M0 IIIB 6
101 56 M Liver hepatocellular carcinoma, well differentiated T1N0M0 I 6
102 54 M Liver hepatocellular carcinoma, well differentiated T2N0M0 II 6
103 54 M Liver hepatocellular carcinoma, moderately differentiated T2N0M0 II 6
104 62 M Liver hepatocellular carcinoma, moderately differentiated T3N0M0 IIIA 6
105 45 M Liver hepatocellular carcinoma, moderately differentiated T2N0M0 II 6
106 51 M Liver hepatocellular carcinoma, moderately differentiated T2N0M0 II 6
107 77 M Liver hepatocellular carcinoma, moderately differentiated T2N0M0 II 6
108 59 F Liver hepatocellular carcinoma, moderately differentiated T2N0M0 II 6
109 64 M Liver hepatocellular carcinoma, moderately differentiated T2N0M0 II 6
110 67 F Liver hepatocellular carcinoma, poorly differentiated T2N0M0 II 6
111 53 M Liver hepatocellular carcinoma, metastasis to abdominal cavity M1 IV 6
112 52 M Liver hepatocellular carcinoma, metastasis to abdominal wall M1 IV 6
113 31 F Liver hepatocellular carcinoma, metastasis to pelvic cavity M1 IV 6
114 54 F Biliary, common bile duct adenocarcinoma, well differentiated T3N1M0 IIB 6
115 67 F Biliary, gallbladder adenocarcinoma, moderately differentiated T3N0M0 IIA 6
116 45 F Biliary, common bile duct adenocarcinoma, moderately differentiated T3N0M0 IIA 6
117 64 F Biliary, gallbladder adenocarcinoma, moderately differentiated T3N1M0 IIB 6
118 52 F Biliary, gallbladder adenocarcinoma, poorly differentiated T3N0M0 IIA 6
119 66 F Biliary, gallbladder adenosquamous cell carcinoma T3N0M0 IIA 6
120 71 M Pancreas adenocarcinoma, moderately differentiated T3N1M0 IIB 6
121 54 M Pancreas adenocarcinoma, moderately differentiated T3N1M0 IIB 6
122 57 F Pancreas adenocarcinoma, moderately differentiated T4N0M0 III 6
123 71 M Pancreas adenocarcinoma, moderately differentiated T4N0M0 III 6
124 42 F Pancreas adenocarcinoma, poorly differentiated T4N1M0 III 6
125 67 M Larynx squamous cell carcinoma, well differentiated T4aN2bM0 IVA 6
126 81 F Larynx squamous cell carcinoma, well differentiated T3N0M0 III 6
127 71 M Larynx squamous cell carcinoma, well differentiated T4aN1M0 IVA 6
128 67 M Larynx squamous cell carcinoma, well differentiated T4aN0M0 IVA 6
129 52 M Larynx squamous cell carcinoma, well differentiated T1N2cM0 IVA 6
130 54 M Larynx squamous cell carcinoma, well differentiated T3N0M0 III 6
131 60 M Larynx squamous cell carcinoma, well differentiated T4aN0M0 IVA 6
132 66 M Larynx squamous cell carcinoma, well differentiated T3N0M0 III 6
133 57 M Larynx squamous cell carcinoma, well differentiated T4aN1M0 IVA 6
134 46 M Larynx squamous cell carcinoma, well differentiated T4aN2aM0 IVA 6
135 66 M Larynx squamous cell carcinoma, well differentiated T2N1M0 III 6
136 57 M Larynx squamous cell carcinoma, moderately differentiated T4aN0M0 IVA 6
137 64 M Larynx squamous cell carcinoma, moderately differentiated T4aN0M0 IVA 6
138 68 M Larynx squamous cell carcinoma, moderately differentiated T4aN2bM0 IVA 6
139 57 M Larynx squamous cell carcinoma, metastasis to lung M1 IVC 6
140 62 M Lung adenocarcinoma, well differentiated T2N0M0 I B 6
141 26 M Lung adenocarcinoma, well differentiated T2N1M0 IIB 6
142 57 M Lung adenocarcinoma, well differentiated T2N2M0 IIIA 6
143 60 F Lung adenocarcinoma, moderately differentiated T2N2M0 IIIA 6
144 71 M Lung adenocarcinoma, modetately differentiated T2N0M0 I B 6
145 . . Carbon . . . .
146 31 M Lung adenocarcinoma, moderately differentiated, mucinous T2N0M0 I B 6
147 62 M Lung adenocarcinoma, well differentiated, papillary T2N0M0 I B 6
148 63 M Lung adenocarcinoma, poorly differentiated T2N0M0 I B 6
149 47 M Lung bronchioloalveolar carcinoma T2N1M0 II B 6
150 . . Carbon . . . .


Applications/Dilutions

Publications
Read Publications using NBP2-30329.

Reactivity Notes

Human

Packaging, Storage & Formulations

Storage
Store at 4C. Do not freeze.

Details for Various

Type
Tissue
Tissue Condition
Cancer

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Tissue Micro Arrays are guaranteed for 1 year from date of receipt.

Publications for Various Tissue Micro Array (NBP2-30329)(3)

Reviews for Various Tissue Micro Array (NBP2-30329) (0)

There are no reviews for Various Tissue Micro Array (NBP2-30329). By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
  • Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
  • Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen
  • 1st to review with an image -- $50/€35/£30/$50 CAD/¥300 Yuan/¥5000 Yen

Product General Protocols

Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.

FAQs for Various Tissue Micro Array (NBP2-30329) (0)

There are no specific FAQs related to this product. Read our general customer & technical service FAQs.

Additional Various Products

Various NBP2-30329

Blogs on Various

There are no specific blogs for Various, but you can read our latest blog posts.

Contact Information

Product PDFs

Review this Product

Be the first to review our Human Various Tissue MicroArray (Cancer) and receive a gift card or discount.